• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
View Item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Zika virus detection in urine from patients with Guillain-Barre syndrome on Martinique, January 2016

 
Thumbnail
Date
2016-06
Author
Rozé, Benoît
Najioullah, Fatiha
Fergé, Jean-Louis
et al.
Metadata
Show full item record
Abstract
Two cases of Guillain–Barré syndrome (GBS) were diagnosed in January 2016 on Martinique, a French West Indies island of 390,000 inhabitants. Both patients were found to have ZikV in their urine at hospital admission. An outbreak of Zika virus (ZikV) infections has been ongoing on the island since December 2015 [1] and spread rapidly, with more than 1,000 estimated cases per week in 2016 [2]. ZikV infection is usually benign, when symptomatic. The disease is a dengue-like syndrome, characterised by fever, headache, retro-orbital pain, non-purulent conjunctivitis, maculopapular rash, arthralgia, and myalgia. The symptoms last for four to seven days and are self-limiting. Recent ZikV epidemics in French Polynesia, Brazil and Central America have been associated with Guillain–Barré syndrome (GBS) outbreaks, the probable link between these two diseases was made based on serological and anamnestic data.
URI
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.9.30154
Collections
  • Technical documents and research evidence on COVID-19

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CollectionBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)